Perrigo Co PLC (PRGO)
32.79
-0.27
(-0.82%)
USD |
NYSE |
May 03, 16:00
32.79
0.00 (0.00%)
After-Hours: 20:00
Perrigo Cash from Investing (Quarterly): -22.80M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -22.80M |
September 30, 2023 | -30.70M |
June 30, 2023 | -4.40M |
March 31, 2023 | -19.60M |
December 31, 2022 | -26.00M |
September 30, 2022 | -20.90M |
June 30, 2022 | -1.974B |
March 31, 2022 | 62.70M |
December 31, 2021 | -41.90M |
September 30, 2021 | 1.454B |
June 30, 2021 | -21.80M |
March 31, 2021 | -114.00M |
December 31, 2020 | -127.50M |
September 30, 2020 | -38.60M |
June 30, 2020 | 53.10M |
March 31, 2020 | -74.80M |
December 31, 2019 | -106.30M |
September 30, 2019 | -651.80M |
June 30, 2019 | -68.10M |
March 31, 2019 | 230.10M |
December 31, 2018 | -46.10M |
September 30, 2018 | -51.50M |
June 30, 2018 | -27.10M |
March 31, 2018 | -2.10M |
December 31, 2017 | 66.00M |
Date | Value |
---|---|
September 30, 2017 | -9.90M |
June 30, 2017 | -5.80M |
March 31, 2017 | 2.288B |
December 31, 2016 | 94.50M |
September 30, 2016 | 38.40M |
June 30, 2016 | 144.20M |
March 31, 2016 | -452.10M |
September 30, 2015 | -448.70M |
June 30, 2015 | -1.812B |
March 31, 2015 | -333.90M |
December 31, 2014 | -125.90M |
September 30, 2014 | -30.70M |
June 30, 2014 | 1.40M |
March 31, 2014 | -46.20M |
December 31, 2013 | -1.564B |
September 30, 2013 | -35.80M |
June 30, 2013 | -285.10M |
March 31, 2013 | -296.50M |
December 31, 2012 | -351.40M |
September 30, 2012 | -14.80M |
June 30, 2012 | -25.81M |
March 31, 2012 | -65.33M |
December 31, 2011 | -37.21M |
September 30, 2011 | -555.76M |
June 30, 2011 | -53.68M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.974B
Minimum
Jun 2022
1.454B
Maximum
Sep 2021
-93.38M
Average
-30.70M
Median
Sep 2023
Cash from Investing (Quarterly) Benchmarks
Alkermes PLC | -39.95M |
Endo International PLC | -11.65M |
Jazz Pharmaceuticals PLC | -271.90M |
Medtronic PLC | -707.00M |
Iterum Therapeutics PLC | 13.52M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 208.70M |
Cash from Financing (Quarterly) | -44.60M |
Free Cash Flow | 303.80M |
Free Cash Flow Per Share (Quarterly) | 1.342 |
Free Cash Flow to Equity (Quarterly) | 195.20M |
Free Cash Flow to Firm (Quarterly) | 203.78M |
Free Cash Flow Yield | 6.81% |